BioDelivery Sciences to Report Second Quarter 2019 Financial Results and Host Conference Call on August 8, 2019
July 30 2019 - 7:45AM
BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a
specialty pharmaceutical company dedicated to patients living with
chronic conditions, today announced its plans to report its
second-quarter 2019 financial results after the close of the U.S.
financial markets on Thursday, August 8, 2019. The company
will host a conference call and webcast at 4:30 PM EDT to
discuss the results and provide an update on business operations.
Conference Call Dial-In & Webcast
Information:
Date: |
Thursday, August 8, 2019 |
|
|
Time: |
4:30 PM EDT |
|
|
Domestic: |
800-347-6311 |
|
|
International: |
720-543-0197 |
|
|
Passcode: |
868 4665 |
|
|
Webcast: |
http://public.viavid.com/index.php?id=135544 |
About BioDelivery Sciences
International, Inc.
BioDelivery Sciences International,
Inc. (NASDAQ: BDSI) is a specialty pharmaceutical company
dedicated to patients living with chronic conditions. BDSI is
utilizing its novel and proprietary BioErodible MucoAdhesive
(BEMA®) technology and other drug delivery technologies to develop
and commercialize, either on its own or in partnership with third
parties, new applications of proven therapies aimed at addressing
important unmet medical needs. BDSI's marketed products and those
in development address serious and debilitating conditions such as
chronic pain, breakthrough cancer pain, and opioid dependence. For
more information, please visit us https://bdsi.com or follow us on
Facebook or Twitter BDSI @BioDeliverySI.
© 2019 BioDelivery Sciences International,
Inc. All rights reserved.
Contact Mary Coleman Vice
President, Investor Relations and Corporate Communications
BioDelivery Sciences International, Inc.
919-582-9050mcoleman@bdsi.com
BioDelivery Sciences (NASDAQ:BDSI)
Historical Stock Chart
From Mar 2024 to Apr 2024
BioDelivery Sciences (NASDAQ:BDSI)
Historical Stock Chart
From Apr 2023 to Apr 2024